Indefinite Delivery Contract SPE2DX15D9354

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. The IDC has an ultimate completion date of December 31, 2025, and does not utilize any set-aside designations, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across multiple product categories and medical domains. The delivery orders issued under this IDC are being performed at DMS Pharmaceutical Group's facility in Park Ridge, Illinois, supporting the DLA's TRICARE West program.